Learning Objectives:

1. To provide an overview of the current approach to pediatric ALL therapy

2. To understand the factors that go into risk stratification of pediatric patients with ALL

3. To describe how targeted therapies are being incorporated into frontline treatment for newly diagnosed patients

Session date: 
04/30/2020 - 12:00pm to 1:00pm CDT
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Jennifer McNeer, MD